Review



recombinant mouse hb-egf protein novus nbp2-35069  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Novus Biologicals recombinant mouse hb-egf protein novus nbp2-35069
    Recombinant Mouse Hb Egf Protein Novus Nbp2 35069, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse hb-egf protein novus nbp2-35069/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    recombinant mouse hb-egf protein novus nbp2-35069 - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    agents 463 recombinant hbegf  (MedChemExpress)
    93
    MedChemExpress agents 463 recombinant hbegf
    Agents 463 Recombinant Hbegf, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/agents 463 recombinant hbegf/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    agents 463 recombinant hbegf - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    cell through elisa  (R&D Systems)
    93
    R&D Systems cell through elisa
    <t>HB-EGF</t> increases early after the induction of MTLE in vivo and is secreted by NSPCs in vitro. (A) Confocal microscopy images from Nestin-GFP mice, 14dpKA showing the reduction caused by gefitinib of the MTLE-induced GCD and NSC overactivation. Scale bar, 20 μm. (B) Quantification of the volume of the GCL in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (C) Quantification of the BrdU+ cells in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (D) Quantification of BrdU+ NSCs, ANPs, and overall cells in the SGZ expressed as the percentage with respect to KA+DMSO animals. (E) Confocal microscopy images showing an increase in the EGFR ligand HB-EGF in the hilus and the molecular layer of Nestin-GFP mice 3dpKA. Scale bar, 20 μm. (F) Quantification of HB-EGF by <t>ELISA</t> at different time points during the first 3dpKA. Values are represented as the pg of HB-EGF in 100 μg of the tissue. (G) Immunofluorescence images of NSPCs in vitro showing HB-EGF expression. Scale bar, 10 μm. (H) Quantification by ELISA of HB-EGF released in vitro, expressed as the pg of the ligand per mL. Dots show individual data. Data information: for (B), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (C), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (D), t test, ** P < 0.01. Bars show the mean ± SEM. Dots show individual data. For (F), one-way ANOVA, * P < 0.05 and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (H), Kruskal–Wallis test, * P < 0.05. Bars show the mean ± SEM. Source data are available for this figure.
    Cell Through Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell through elisa/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    cell through elisa - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    recombinant mouse hb-egf protein  (ProSpec)
    90
    ProSpec recombinant mouse hb-egf protein
    <t>HB-EGF</t> increases early after the induction of MTLE in vivo and is secreted by NSPCs in vitro. (A) Confocal microscopy images from Nestin-GFP mice, 14dpKA showing the reduction caused by gefitinib of the MTLE-induced GCD and NSC overactivation. Scale bar, 20 μm. (B) Quantification of the volume of the GCL in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (C) Quantification of the BrdU+ cells in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (D) Quantification of BrdU+ NSCs, ANPs, and overall cells in the SGZ expressed as the percentage with respect to KA+DMSO animals. (E) Confocal microscopy images showing an increase in the EGFR ligand HB-EGF in the hilus and the molecular layer of Nestin-GFP mice 3dpKA. Scale bar, 20 μm. (F) Quantification of HB-EGF by <t>ELISA</t> at different time points during the first 3dpKA. Values are represented as the pg of HB-EGF in 100 μg of the tissue. (G) Immunofluorescence images of NSPCs in vitro showing HB-EGF expression. Scale bar, 10 μm. (H) Quantification by ELISA of HB-EGF released in vitro, expressed as the pg of the ligand per mL. Dots show individual data. Data information: for (B), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (C), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (D), t test, ** P < 0.01. Bars show the mean ± SEM. Dots show individual data. For (F), one-way ANOVA, * P < 0.05 and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (H), Kruskal–Wallis test, * P < 0.05. Bars show the mean ± SEM. Source data are available for this figure.
    Recombinant Mouse Hb Egf Protein, supplied by ProSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse hb-egf protein/product/ProSpec
    Average 90 stars, based on 1 article reviews
    recombinant mouse hb-egf protein - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    recombinant mouse hb-egf protein novus nbp2-35069  (Novus Biologicals)
    90
    Novus Biologicals recombinant mouse hb-egf protein novus nbp2-35069
    <t>HB-EGF</t> increases early after the induction of MTLE in vivo and is secreted by NSPCs in vitro. (A) Confocal microscopy images from Nestin-GFP mice, 14dpKA showing the reduction caused by gefitinib of the MTLE-induced GCD and NSC overactivation. Scale bar, 20 μm. (B) Quantification of the volume of the GCL in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (C) Quantification of the BrdU+ cells in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (D) Quantification of BrdU+ NSCs, ANPs, and overall cells in the SGZ expressed as the percentage with respect to KA+DMSO animals. (E) Confocal microscopy images showing an increase in the EGFR ligand HB-EGF in the hilus and the molecular layer of Nestin-GFP mice 3dpKA. Scale bar, 20 μm. (F) Quantification of HB-EGF by <t>ELISA</t> at different time points during the first 3dpKA. Values are represented as the pg of HB-EGF in 100 μg of the tissue. (G) Immunofluorescence images of NSPCs in vitro showing HB-EGF expression. Scale bar, 10 μm. (H) Quantification by ELISA of HB-EGF released in vitro, expressed as the pg of the ligand per mL. Dots show individual data. Data information: for (B), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (C), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (D), t test, ** P < 0.01. Bars show the mean ± SEM. Dots show individual data. For (F), one-way ANOVA, * P < 0.05 and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (H), Kruskal–Wallis test, * P < 0.05. Bars show the mean ± SEM. Source data are available for this figure.
    Recombinant Mouse Hb Egf Protein Novus Nbp2 35069, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse hb-egf protein novus nbp2-35069/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    recombinant mouse hb-egf protein novus nbp2-35069 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    mouse hb-egf elisa kit rk02882  (ABclonal Biotechnology)
    90
    ABclonal Biotechnology mouse hb-egf elisa kit rk02882
    <t>HB-EGF</t> increases early after the induction of MTLE in vivo and is secreted by NSPCs in vitro. (A) Confocal microscopy images from Nestin-GFP mice, 14dpKA showing the reduction caused by gefitinib of the MTLE-induced GCD and NSC overactivation. Scale bar, 20 μm. (B) Quantification of the volume of the GCL in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (C) Quantification of the BrdU+ cells in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (D) Quantification of BrdU+ NSCs, ANPs, and overall cells in the SGZ expressed as the percentage with respect to KA+DMSO animals. (E) Confocal microscopy images showing an increase in the EGFR ligand HB-EGF in the hilus and the molecular layer of Nestin-GFP mice 3dpKA. Scale bar, 20 μm. (F) Quantification of HB-EGF by <t>ELISA</t> at different time points during the first 3dpKA. Values are represented as the pg of HB-EGF in 100 μg of the tissue. (G) Immunofluorescence images of NSPCs in vitro showing HB-EGF expression. Scale bar, 10 μm. (H) Quantification by ELISA of HB-EGF released in vitro, expressed as the pg of the ligand per mL. Dots show individual data. Data information: for (B), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (C), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (D), t test, ** P < 0.01. Bars show the mean ± SEM. Dots show individual data. For (F), one-way ANOVA, * P < 0.05 and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (H), Kruskal–Wallis test, * P < 0.05. Bars show the mean ± SEM. Source data are available for this figure.
    Mouse Hb Egf Elisa Kit Rk02882, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse hb-egf elisa kit rk02882/product/ABclonal Biotechnology
    Average 90 stars, based on 1 article reviews
    mouse hb-egf elisa kit rk02882 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    hb egf antibody  (R&D Systems)
    93
    R&D Systems hb egf antibody
    <t>HB-EGF</t> increases early after the induction of MTLE in vivo and is secreted by NSPCs in vitro. (A) Confocal microscopy images from Nestin-GFP mice, 14dpKA showing the reduction caused by gefitinib of the MTLE-induced GCD and NSC overactivation. Scale bar, 20 μm. (B) Quantification of the volume of the GCL in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (C) Quantification of the BrdU+ cells in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (D) Quantification of BrdU+ NSCs, ANPs, and overall cells in the SGZ expressed as the percentage with respect to KA+DMSO animals. (E) Confocal microscopy images showing an increase in the EGFR ligand HB-EGF in the hilus and the molecular layer of Nestin-GFP mice 3dpKA. Scale bar, 20 μm. (F) Quantification of HB-EGF by <t>ELISA</t> at different time points during the first 3dpKA. Values are represented as the pg of HB-EGF in 100 μg of the tissue. (G) Immunofluorescence images of NSPCs in vitro showing HB-EGF expression. Scale bar, 10 μm. (H) Quantification by ELISA of HB-EGF released in vitro, expressed as the pg of the ligand per mL. Dots show individual data. Data information: for (B), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (C), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (D), t test, ** P < 0.01. Bars show the mean ± SEM. Dots show individual data. For (F), one-way ANOVA, * P < 0.05 and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (H), Kruskal–Wallis test, * P < 0.05. Bars show the mean ± SEM. Source data are available for this figure.
    Hb Egf Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hb egf antibody/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    hb egf antibody - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    recombinant mouse hb egf protein  (Novus Biologicals)
    93
    Novus Biologicals recombinant mouse hb egf protein
    <t>HB-EGF</t> increases early after the induction of MTLE in vivo and is secreted by NSPCs in vitro. (A) Confocal microscopy images from Nestin-GFP mice, 14dpKA showing the reduction caused by gefitinib of the MTLE-induced GCD and NSC overactivation. Scale bar, 20 μm. (B) Quantification of the volume of the GCL in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (C) Quantification of the BrdU+ cells in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (D) Quantification of BrdU+ NSCs, ANPs, and overall cells in the SGZ expressed as the percentage with respect to KA+DMSO animals. (E) Confocal microscopy images showing an increase in the EGFR ligand HB-EGF in the hilus and the molecular layer of Nestin-GFP mice 3dpKA. Scale bar, 20 μm. (F) Quantification of HB-EGF by <t>ELISA</t> at different time points during the first 3dpKA. Values are represented as the pg of HB-EGF in 100 μg of the tissue. (G) Immunofluorescence images of NSPCs in vitro showing HB-EGF expression. Scale bar, 10 μm. (H) Quantification by ELISA of HB-EGF released in vitro, expressed as the pg of the ligand per mL. Dots show individual data. Data information: for (B), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (C), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (D), t test, ** P < 0.01. Bars show the mean ± SEM. Dots show individual data. For (F), one-way ANOVA, * P < 0.05 and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (H), Kruskal–Wallis test, * P < 0.05. Bars show the mean ± SEM. Source data are available for this figure.
    Recombinant Mouse Hb Egf Protein, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse hb egf protein/product/Novus Biologicals
    Average 93 stars, based on 1 article reviews
    recombinant mouse hb egf protein - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    mouse monoclonal hbegf  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology mouse monoclonal hbegf
    <t>HB-EGF</t> increases early after the induction of MTLE in vivo and is secreted by NSPCs in vitro. (A) Confocal microscopy images from Nestin-GFP mice, 14dpKA showing the reduction caused by gefitinib of the MTLE-induced GCD and NSC overactivation. Scale bar, 20 μm. (B) Quantification of the volume of the GCL in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (C) Quantification of the BrdU+ cells in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (D) Quantification of BrdU+ NSCs, ANPs, and overall cells in the SGZ expressed as the percentage with respect to KA+DMSO animals. (E) Confocal microscopy images showing an increase in the EGFR ligand HB-EGF in the hilus and the molecular layer of Nestin-GFP mice 3dpKA. Scale bar, 20 μm. (F) Quantification of HB-EGF by <t>ELISA</t> at different time points during the first 3dpKA. Values are represented as the pg of HB-EGF in 100 μg of the tissue. (G) Immunofluorescence images of NSPCs in vitro showing HB-EGF expression. Scale bar, 10 μm. (H) Quantification by ELISA of HB-EGF released in vitro, expressed as the pg of the ligand per mL. Dots show individual data. Data information: for (B), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (C), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (D), t test, ** P < 0.01. Bars show the mean ± SEM. Dots show individual data. For (F), one-way ANOVA, * P < 0.05 and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (H), Kruskal–Wallis test, * P < 0.05. Bars show the mean ± SEM. Source data are available for this figure.
    Mouse Monoclonal Hbegf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse monoclonal hbegf/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    mouse monoclonal hbegf - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    HB-EGF increases early after the induction of MTLE in vivo and is secreted by NSPCs in vitro. (A) Confocal microscopy images from Nestin-GFP mice, 14dpKA showing the reduction caused by gefitinib of the MTLE-induced GCD and NSC overactivation. Scale bar, 20 μm. (B) Quantification of the volume of the GCL in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (C) Quantification of the BrdU+ cells in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (D) Quantification of BrdU+ NSCs, ANPs, and overall cells in the SGZ expressed as the percentage with respect to KA+DMSO animals. (E) Confocal microscopy images showing an increase in the EGFR ligand HB-EGF in the hilus and the molecular layer of Nestin-GFP mice 3dpKA. Scale bar, 20 μm. (F) Quantification of HB-EGF by ELISA at different time points during the first 3dpKA. Values are represented as the pg of HB-EGF in 100 μg of the tissue. (G) Immunofluorescence images of NSPCs in vitro showing HB-EGF expression. Scale bar, 10 μm. (H) Quantification by ELISA of HB-EGF released in vitro, expressed as the pg of the ligand per mL. Dots show individual data. Data information: for (B), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (C), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (D), t test, ** P < 0.01. Bars show the mean ± SEM. Dots show individual data. For (F), one-way ANOVA, * P < 0.05 and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (H), Kruskal–Wallis test, * P < 0.05. Bars show the mean ± SEM. Source data are available for this figure.

    Journal: Life Science Alliance

    Article Title: HB-EGF activates EGFR to induce reactive neural stem cells in the mouse hippocampus after seizures

    doi: 10.26508/lsa.202201840

    Figure Lengend Snippet: HB-EGF increases early after the induction of MTLE in vivo and is secreted by NSPCs in vitro. (A) Confocal microscopy images from Nestin-GFP mice, 14dpKA showing the reduction caused by gefitinib of the MTLE-induced GCD and NSC overactivation. Scale bar, 20 μm. (B) Quantification of the volume of the GCL in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (C) Quantification of the BrdU+ cells in saline+DMSO–, saline+ gefitinib–, KA+DMSO–, and KA+gefitinib–treated animals 14dpKA. (D) Quantification of BrdU+ NSCs, ANPs, and overall cells in the SGZ expressed as the percentage with respect to KA+DMSO animals. (E) Confocal microscopy images showing an increase in the EGFR ligand HB-EGF in the hilus and the molecular layer of Nestin-GFP mice 3dpKA. Scale bar, 20 μm. (F) Quantification of HB-EGF by ELISA at different time points during the first 3dpKA. Values are represented as the pg of HB-EGF in 100 μg of the tissue. (G) Immunofluorescence images of NSPCs in vitro showing HB-EGF expression. Scale bar, 10 μm. (H) Quantification by ELISA of HB-EGF released in vitro, expressed as the pg of the ligand per mL. Dots show individual data. Data information: for (B), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (C), Kruskal–Wallis test, * P < 0.05, * P < 0.01, and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (D), t test, ** P < 0.01. Bars show the mean ± SEM. Dots show individual data. For (F), one-way ANOVA, * P < 0.05 and *** P < 0.001. Bars show the mean ± SEM. Dots show individual data. For (H), Kruskal–Wallis test, * P < 0.05. Bars show the mean ± SEM. Source data are available for this figure.

    Article Snippet: Next, we determined the amount of HB-EGF per cell through ELISA (Cat#DY8239-05; R&D Systems).

    Techniques: In Vivo, In Vitro, Confocal Microscopy, Saline, Enzyme-linked Immunosorbent Assay, Immunofluorescence, Expressing